10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||||||||||||
| |||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
REGENERON PHARMACEUTICALS, INC. | ||
Ticker: REGN Fiscal Year: 2011 | ||
BALANCE SHEETS | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 21, 2012) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2011 | Dec 31, 2010 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $ 483,610 | 112,572 |
| Marketable securities | 43,332 | 136,796 |
| Accounts receivable from Sanofi | 74,781 | 79,603 |
| Accounts receivable - trade, net | 28,254 | 2,314 |
| Prepaid expenses and other current assets | 22,898 | 26,337 |
| Total current assets | 652,875 | 357,622 |
| Restricted cash and marketable securities | 7,721 | 7,518 |
| Marketable securities | 275,887 | 370,053 |
| Property, plant, and equipment, at cost, net of accumulated depreciation and amortization | 367,955 | 347,450 |
| Other assets | 19,145 | 6,789 |
| Total assets | 1,323,583 | 1,089,432 |
| LIABILITIES and STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | 95,625 | 53,658 |
| Deferred revenue from Sanofi, current portion | 20,011 | 19,506 |
| Deferred revenue - other, current portion | 31,629 | 35,217 |
| Facility lease obligations, current portion | 1,006 | 675 |
| Total current liabilities | 148,271 | 109,056 |
| Deferred revenue from Sanofi | 86,017 | 97,081 |
| Deferred revenue - other | 162,593 | 188,775 |
| Facility lease obligations | 159,508 | 159,355 |
| Convertible senior notes | 275,019 | 0 |
| Other long term liabilities | 6,443 | 7,350 |
| Total liabilities | 837,851 | 561,617 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity | ||
| Preferred stock | 0 | 0 |
| Common Stock | 91 | 87 |
| Additional paid-in capital | 1,754,824 | 1,575,780 |
| Accumulated deficit | (1,267,323) | (1,045,563) |
| Accumulated other comprehensive loss | (1,862) | (2,491) |
| Total stockholders' equity | 485,732 | 527,815 |
| Total liabilities and stockholders' equity | 1,323,583 | 1,089,432 |
| Class of Stock | ||
| Class A Stock | ||
| Common Stock | 2 | 2 |
| External Links | |
| REGENERON PHARMACEUTICALS, INC. (REGN) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |